Clinical Trials Logo

Endothelial Dysfunction clinical trials

View clinical trials related to Endothelial Dysfunction.

Filter by:

NCT ID: NCT04357847 Recruiting - Covid-19 Clinical Trials

Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection

Covid-Thelium
Start date: April 9, 2020
Phase:
Study type: Observational

The outbreak at covid-19 is caused by the SARS-CoV-2 virus. This virus can be responsible for severe respiratory failure but also for extra-respiratory organ dysfunctions associated with severe inflammatory stress. The endothelium is an important structure of the blood vessels and is implicated in the organ failure of many patients admitted in intensive care units. It could be affected by the virus and its alteration may explain the organ dysfunction of covid-19 ICU patients as well as the thrombotic processes frequently obstructed in this infection.

NCT ID: NCT04337385 Terminated - Clinical trials for Endothelial Dysfunction

Interrupting Sitting With High Intensity Exercise on Vascular Function in Adolescents Before and After a Mixed Meal

Start date: March 4, 2020
Phase: N/A
Study type: Interventional

This study aims to investigate the effect of interrupting a three hour bout of prolonged sitting with high intensity interval exercise on lower limb blood vessel function in adolescents before and after a mixed meal challenge.

NCT ID: NCT04302571 Active, not recruiting - Clinical trials for Peripheral Arterial Disease

Effects of Combined Aerobic and Resistance Training in Patients With Intermittent Claudication

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

Exercise training improves walking capacity and regional perfusion in patients with Intermittent Claudication (IC). Endothelial Progenitor Cells (EPCs) and Endothelial Microparticles (EMPs) could play an important role in this process, promoting the healing of the diseased endothelium. The investigators are going to measure EPCs and EMPs in a group of patients with IC and in a control group of healthy individuals before a treadmill test and 2, 24, and 48 hours after the test. Subsequently, a group of IC patients will be randomly assigned to perform a 12-week home-based exercise training program. The investigators expect a significant increase of EMPs and EPCs after acute and chronic physical activity. We expect also a correlation between the increase of EMPs and EPCs and the improvement in walking capacity. Aim of the study is to demonstrate that acutely performed aerobic exercise could be able to promote the mobilization of EMPs and EPCs in patients with IC and that endothelial progenitor cells mobilization could play a pivotal role in exercise induced improvement of walking performance and endothelial function in subjects with IC.

NCT ID: NCT04283630 Completed - Clinical trials for Endothelial Dysfunction

Nitrate and Vitamin C on Vascular Health Oxidative Stress

Start date: February 5, 2018
Phase: N/A
Study type: Interventional

The objective of this study is to examine whether the co-administration of dietary nitrate combined with vitamin C for 4 weeks in patients at risk for CVD would yield robust effects on endothelial function using blood measures and a non-invasive technique (Peripheral Artery Tonometry) compared to dietary nitrate supplementation alone.

NCT ID: NCT04202172 Completed - Clinical trials for Myocardial Infarction

Functional Assessment of the Infart-related Artery With Bioactive and Polymer-free Coronary Stents (The FUNCOMBO Trial)

FUNCOMBO
Start date: November 5, 2018
Phase: Phase 4
Study type: Interventional

A total of 50 patients with ST-elevation myocardial infarction (STEMI) undergoing primary-percutaneous coronary intervention (PPCI) will be randomized to two different coronary stents: BIOFREEDOM vs. COMBO stent. All patients will undergo to 6-month scheduled coronary angiography to evaluate the endothelial function response of the distal coronary segment and other functional parameters.

NCT ID: NCT04181398 Active, not recruiting - Obesity Clinical Trials

Low Grade Inflammation in Childhood Obesity : an Independent Risk Factor for Endothelial Dysfunction

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

Eligible candidates will be recruited within the children with overweight and obesity having a metabolic risk evaluation before treatment in the period 2006 and 2010 at the pediatric clinic of the UZ Brussel In total 60 participants will be investigated. Firstly, 30 participating patients with initially elevated hsCRP will be selected at random ( following the date of their initial investigation) and afterwards matched for age, BMI z-score, and blood pressure with the same number of patients without initially elevated hCRP values Data will be collected as follows: - questionnaires - clinical examination/ anthropometry - blood sample (hsCRP) - peripheral arterial tonometry (endoPAT)

NCT ID: NCT04180137 Completed - Clinical trials for Endothelial Dysfunction

Management of Endothelial Dysfunction in Patients With Chronic Venous Insufficiency After Endovenous Surgical Procedure

Start date: November 28, 2019
Phase: N/A
Study type: Interventional

Endothelial dysfunction is assessed in patients with chronic venous insufficiency of lower limbs (grade C4 according to C - clinical manifestations, E - etiologic factors, A - anatomic distribution of disease, and P - underlying pathophysiologic findings (CEAP) classification) prior to and after endovenous surgical procedure, i.e. endovenous laser ablation of great saphenous vein, microphlebectomy of varicose branches. Two treatment groups (with and without additional pharmacotherapy) are compared.

NCT ID: NCT04161339 Recruiting - Clinical trials for Coronary Artery Disease

Anti-Inflammatory Drug and Endothelial Function

HOLD
Start date: July 1, 2019
Phase: Phase 4
Study type: Interventional

In this randomized double-blinded clinical trial, 400mg of hydroxychloroquine will be given daily to people over the age of 65 years with moderate-severe obstructive sleep apnea for 8 weeks. The aim of this study is to test whether hydroxychloroquine can improve endothelial function.

NCT ID: NCT04156711 Completed - Clinical trials for Endothelial Dysfunction

Remote Ischemic Preconditioning in Patients Undergoing Acute Minor Abdominal Surgery

PUMAS
Start date: September 4, 2019
Phase: N/A
Study type: Interventional

This study examines if remote ischemic preconditioning in patients undergoing minor acute abdominal surgery (laparoscopic cholecystitis due to acute cholecystitis) is associated with a modulation of endothelial dysfunction. half of the patients will receive remote ischemic preconditioning prior to surgery, the other half will serve as controls.

NCT ID: NCT04133376 Completed - Smoking Clinical Trials

Electronic Hookah and Endothelial Cell Function

Start date: November 1, 2019
Phase: N/A
Study type: Interventional

Electronic nicotine delivery systems (ENDS) are a rapidly growing global epidemic among adolescents and young adults. Unlike other ENDS such as e-cigarettes, e-hookahs are used through traditional water-pipes, allowing the vapor-containing nicotine, propylene glycol, glycerin, and flavorings-to pass through a water-filled basin, potentially altering the vapor, before it is inhaled through the user's mouth. Contributing to e-hookahs popularity is the belief that the flavored smoke is detoxified as it passes through the water-filled basin, rendering e-hookah a safer tobacco alternative. However, an e-hookahs deliver flavored nicotine by creating a vapor of fine particles and volatile organic compounds that could induce vascular toxicity. While e-hookah vaping acutely reduces endothelial function, the specific role of nicotine and the mechanisms by which it may impairs endothelial function remain understudied. The objective of this project is to investigate the specific role of nicotine in mediating the acute effects of e-hookah vaping on endothelial dysfunction.